Literature DB >> 9218433

NMR spectroscopic studies of the DNA-binding domain of the monomer-binding nuclear orphan receptor, human estrogen related receptor-2. The carboxyl-terminal extension to the zinc-finger region is unstructured in the free form of the protein.

D S Sem1, D R Casimiro, S A Kliewer, J Provencal, R M Evans, P E Wright.   

Abstract

Unlike steroid and retinoid receptors, which associate with DNA as dimers, human estrogen related receptor-2 (hERR2) belongs to a growing subclass of nuclear hormone receptors that bind DNA with high affinity as monomers. A carboxyl-terminal extension (CTE) to the zinc-finger domain has been implicated to be responsible for determining the stoichiometry of binding by a nuclear receptor to its response element. To better understand the mechanism by which DNA specificity is achieved, the solution structure of the DNA-binding domain of hERR2 (residues 96-194) consisting of the two putative zinc fingers and the requisite 26-amino acid CTE was analyzed by multidimensional heteronuclear magnetic resonance spectroscopy. The highly conserved zinc-finger region (residues 103-168) has a fold similar to those reported for steroid and retinoid receptors, with two helices that originate from the carboxyl-terminal ends of the two zinc fingers and that pack together orthogonally, forming a hydrophobic core. The CTE element of hERR2 is unstructured and highly flexible, exhibiting nearly random coil chemical shifts, extreme sensitivity of the backbone amide protons to solvent presaturation, and reduced heteronuclear (1H-15N) nuclear Overhauser effect values. This is in contrast to the dimer-binding retinoid X and thyroid hormone receptors, where, in each case, a helix has been observed within the CTE. The implications of this property of the hERR2 CTE are discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9218433     DOI: 10.1074/jbc.272.29.18038

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Differential DNA binding by the androgen and glucocorticoid receptors involves the second Zn-finger and a C-terminal extension of the DNA-binding domains.

Authors:  E Schoenmakers; P Alen; G Verrijdt; B Peeters; G Verhoeven; W Rombauts; F Claessens
Journal:  Biochem J       Date:  1999-08-01       Impact factor: 3.857

Review 2.  General molecular biology and architecture of nuclear receptors.

Authors:  Michal Pawlak; Philippe Lefebvre; Bart Staels
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

3.  Structure of a thyroid hormone receptor DNA-binding domain homodimer bound to an inverted palindrome DNA response element.

Authors:  Yi Chen; Matthew A Young
Journal:  Mol Endocrinol       Date:  2010-07-07

4.  Structure of the progesterone receptor-deoxyribonucleic acid complex: novel interactions required for binding to half-site response elements.

Authors:  Sarah C Roemer; Douglas C Donham; Lori Sherman; Vickie H Pon; Dean P Edwards; Mair E A Churchill
Journal:  Mol Endocrinol       Date:  2006-08-24

Review 5.  Roles of intrinsic disorder in protein-nucleic acid interactions.

Authors:  H Jane Dyson
Journal:  Mol Biosyst       Date:  2011-08-26

Review 6.  Structural and functional analysis of domains of the progesterone receptor.

Authors:  Krista K Hill; Sarah C Roemer; Mair E A Churchill; Dean P Edwards
Journal:  Mol Cell Endocrinol       Date:  2011-07-22       Impact factor: 4.102

7.  Estrogen-related Receptor β Reduces the Subnuclear Mobility of Estrogen Receptor α and Suppresses Estrogen-dependent Cellular Function.

Authors:  Takashi Tanida; Ken Ichi Matsuda; Shunji Yamada; Takashi Hashimoto; Mitsuhiro Kawata
Journal:  J Biol Chem       Date:  2015-03-24       Impact factor: 5.157

8.  The orphan nuclear receptor estrogen-related receptor beta (ERRβ) in triple-negative breast cancer.

Authors:  Aileen I Fernandez; Xue Geng; Krysta Chaldekas; Brent Harris; Anju Duttargi; V Layne Berry; Deborah L Berry; Akanksha Mahajan; Luciane R Cavalli; Balázs Győrffy; Ming Tan; Rebecca B Riggins
Journal:  Breast Cancer Res Treat       Date:  2019-11-19       Impact factor: 4.872

9.  A progesterone receptor co-activator (JDP2) mediates activity through interaction with residues in the carboxyl-terminal extension of the DNA binding domain.

Authors:  Krista K Hill; Sarah C Roemer; David N M Jones; Mair E A Churchill; Dean P Edwards
Journal:  J Biol Chem       Date:  2009-06-24       Impact factor: 5.157

10.  Mechanism of high-mobility group protein B enhancement of progesterone receptor sequence-specific DNA binding.

Authors:  Sarah C Roemer; James Adelman; Mair E A Churchill; Dean P Edwards
Journal:  Nucleic Acids Res       Date:  2008-05-12       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.